methyl 2,4-dihydroxy-3,6-dimethyl benzoate has been researched along with bicalutamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailis, N; Baniahmad, A; Fousteris, MA; Giannis, A; Nikolaropoulos, SS; Roediger, J; Roell, D; Schubert, U | 1 |
1 other study(ies) available for methyl 2,4-dihydroxy-3,6-dimethyl benzoate and bicalutamide
Article | Year |
---|---|
20-Aminosteroids as a novel class of selective and complete androgen receptor antagonists and inhibitors of prostate cancer cell growth.
Topics: Androgen Receptor Antagonists; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Male; Molecular Conformation; Mutation; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stereoisomerism; Steroids; Structure-Activity Relationship | 2010 |